October Pharma profits 57% profit rise
Updated 6/11/2020 3:56:00 PM
ArabFinance: October Pharma (OCPH) posted a 57.5% Year on Year increase in its net profit in Quarter one (Q1) of 2020, according to a June 11th disclosure filed to the Egyptian Exchange.
Net profit reached EGP 8 million in Q1 2020, compared to EGP 3.4 million achieved in the corresponding period.
In April, the shareholders of the company agreed on distributing 15% of the capital as cash dividends for 2019.
The company will pay EGP 1.5 per share dividends for FY 2019. This will have a total value of EGP 6 million to be distributed to the shareholders.
October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations. The company’s major shareholders include Arab Company for Drug Industries & Medical Appliances (ACDIMA) and Saudi Egyptian Industrial Investment Company.
